Effect of generic switch on pharmacy refill compliance after ramipril patent expiry – a retrospective study using the DAPI database

Miriam Ude, Katrin Schüssel, Renate Quinzler, Kristina Leuner, Walter E. Müller & Martin Schulz
Introduction: For treatment success in chronic diseases such as hypertension, adequate adherence to long-term pharmacotherapy is a prerequisite. The purpose of this study was to evaluate whether switching from brand name ramipril to a generic product after patent expiry may negatively affect patients’[for full text, please go to the a.m. URL]